Figure 2From: Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAPSurvival Analysis (2005 - 2007, quarterly). Kaplan Meier Survival Estimates.Back to article page